LAUREN BROADWAY
Allopathic & Osteopathic Physicians|Family Medicine VENICE, FL NPI 1811263643
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Amgen Inc. All categories
General Payments — all program years on this page
$5,653.70
- Category: General Payments
- Program years: PY2018–2024
- Record count: 266
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,198.09 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,198.09 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $175.38 | 10 |
| Merit Medical Systems Inc | $161.41 | 1 |
| Lilly USA, LLC | $160.07 | 8 |
| Acerta Pharma LLC | $141.86 | 7 |
| PFIZER INC. | $81.59 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $76.15 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $69.28 | 4 |
| Novo Nordisk AS | $54.70 | 3 |
| ABBVIE INC. | $50.69 | 3 |
| Janssen Pharmaceuticals, Inc | $29.37 | 1 |
| Otsuka America Pharmaceutical, Inc. | $27.73 | 1 |
| Axsome Therapeutics, Inc. | $27.52 | 1 |
| Phadia US Inc. | $23.64 | 1 |
| Astellas Pharma US Inc | $21.89 | 1 |
| Philips Electronics North America Corporation | $21.29 | 1 |
| Abbott Laboratories | $18.54 | 1 |
| Merck Sharp & Dohme Corporation | $15.80 | 1 |
| GlaxoSmithKline, LLC. | $14.60 | 1 |
| Currax Pharmaceuticals LLC | $13.38 | 1 |
| Kowa Pharmaceuticals America, Inc. | $13.20 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.